DMAA
Drugs Made In America Acquisition Corp.
10.90$
+0.0%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 40.9% | 0.5% | 0.9% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| 9.5% | 0.5% | 245.3% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| 9.5% | 0.5% | 245.3% | 0.0% | 0.0% | 0.0% | – | 0.0% | 0.0% | |
| 110.4% | 138.7% | 144.5% | 3.1% | 3.1% | 3.1% | 3.0% | 3.1% | 6.2% | |
| 110.4% | 138.7% | 144.5% | 0.1% | 0.1% | 0.2% | 0.2% | 0.2% | 2.0% | |
| 110.0% | 129.5% | 120.2% | 0.0% | – | – | – | 0.0% | 0.6% | |
| – | – | – | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.2% | |
| -10.4% | -38.7% | -44.3% | 96.9% | 96.9% | 96.9% | 97.0% | 96.9% | 93.8% | |
| -28.8% | -46.9% | -50.7% | -2.7% | -2.7% | -2.8% | -3.0% | -3.0% | -5.0% | |
| 4,486,025.3% | 2,011.3% | 1,556,043.7% | 11.0% | 14.3% | 9.7% | 14.1% | 9.5% | 13.7% |
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.